Dare Bioscience, Inc.
DARE· Nasdaq
DAREDare Bioscience, Inc.
Filed Mar 28, 2018 · 10-K · 87 days after period end · 0001564590-18-006989
derived · Computed from the longer spans the company filed.
| Metric | Q4 2017dderived from reported figures | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|---|
| Revenue | — | $766.00K | — | $0.00 |
| Net Income | -$9.13M | -$4.95M | -$10.72M | -$7.47M |
| EPS Diluted | — | -$0.17 | -$0.39 | -$0.37 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
ended Dec 31, 2017 · filed Mar 28, 2018 · 87 d after period end
